197 related articles for article (PubMed ID: 22848574)
21. Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and Moloney murine leukemia virus reverse transcriptase.
Gao HQ; Sarafianos SG; Arnold E; Hughes SH
J Mol Biol; 1999 Dec; 294(5):1097-113. PubMed ID: 10600369
[TBL] [Abstract][Full Text] [Related]
22. The role of template-primer in protection of reverse transcriptase from thermal inactivation.
Gerard GF; Potter RJ; Smith MD; Rosenthal K; Dhariwal G; Lee J; Chatterjee DK
Nucleic Acids Res; 2002 Jul; 30(14):3118-29. PubMed ID: 12136094
[TBL] [Abstract][Full Text] [Related]
23. Mechanistic differences in RNA-dependent DNA polymerization and fidelity between murine leukemia virus and HIV-1 reverse transcriptases.
Skasko M; Weiss KK; Reynolds HM; Jamburuthugoda V; Lee K; Kim B
J Biol Chem; 2005 Apr; 280(13):12190-200. PubMed ID: 15644314
[TBL] [Abstract][Full Text] [Related]
24. Fluorescent Tricyclic Cytidine Analogues as Substrates for Retroviral Reverse Transcriptases.
Turner MB; Purse BW
Chempluschem; 2020 May; 85(5):855-865. PubMed ID: 32378814
[TBL] [Abstract][Full Text] [Related]
25. Marked infidelity of human immunodeficiency virus type 1 reverse transcriptase at RNA and DNA template ends.
Patel PH; Preston BD
Proc Natl Acad Sci U S A; 1994 Jan; 91(2):549-53. PubMed ID: 7507249
[TBL] [Abstract][Full Text] [Related]
26. Trans-lesion synthesis and RNaseH activity by reverse transcriptases on a true abasic RNA template.
Küpfer PA; Crey-Desbiolles C; Leumann CJ
Nucleic Acids Res; 2007; 35(20):6846-53. PubMed ID: 17932068
[TBL] [Abstract][Full Text] [Related]
27. Lysine 152 of MuLV reverse transcriptase is required for the integrity of the active site.
Shi Q; Singh K; Srivastava A; Kaushik N; Modak MJ
Biochemistry; 2002 Dec; 41(50):14831-42. PubMed ID: 12475231
[TBL] [Abstract][Full Text] [Related]
28. Photoaffinity labeling of the primer binding domain in murine leukemia virus reverse transcriptase.
Tirumalai RS; Modak MJ
Biochemistry; 1991 Jul; 30(26):6436-43. PubMed ID: 1711370
[TBL] [Abstract][Full Text] [Related]
29. Selection of Primer-Template Sequences That Bind with Enhanced Affinity to Vaccinia Virus E9 DNA Polymerase.
DeStefano JJ; Iseni F; Tarbouriech N
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215961
[TBL] [Abstract][Full Text] [Related]
30. Characterization of Moloney murine leukaemia virus/avian myeloblastosis virus chimeric reverse transcriptases.
Yasukawa K; Mizuno M; Inouye K
J Biochem; 2009 Mar; 145(3):315-24. PubMed ID: 19060310
[TBL] [Abstract][Full Text] [Related]
31. Template-independent DNA synthesis activity associated with the reverse transcriptase of the long terminal repeat retrotransposon Tf1.
Oz-Gleenberg I; Herzig E; Hizi A
FEBS J; 2012 Jan; 279(1):142-53. PubMed ID: 22035236
[TBL] [Abstract][Full Text] [Related]
32. RNase H domain mutations affect the interaction between Moloney murine leukemia virus reverse transcriptase and its primer-template.
Telesnitsky A; Goff SP
Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1276-80. PubMed ID: 7679498
[TBL] [Abstract][Full Text] [Related]
33. Substrate variations that affect the nucleic acid clamp activity of reverse transcriptases.
Oz-Gleenberg I; Herzig E; Voronin N; Hizi A
FEBS J; 2012 May; 279(10):1894-903. PubMed ID: 22443410
[TBL] [Abstract][Full Text] [Related]
34. Crystal structures of an N-terminal fragment from Moloney murine leukemia virus reverse transcriptase complexed with nucleic acid: functional implications for template-primer binding to the fingers domain.
Najmudin S; Coté ML; Sun D; Yohannan S; Montano SP; Gu J; Georgiadis MM
J Mol Biol; 2000 Feb; 296(2):613-32. PubMed ID: 10669612
[TBL] [Abstract][Full Text] [Related]
35. DNA synthesis exhibited by the reverse transcriptase of mouse mammary tumor virus: processivity and fidelity of misinsertion and mispair extension.
Taube R; Avidan O; Bakhanashvili M; Hizi A
Eur J Biochem; 1998 Dec; 258(3):1032-9. PubMed ID: 9990322
[TBL] [Abstract][Full Text] [Related]
36. High processivity of the reverse transcriptase from a non-long terminal repeat retrotransposon.
Bibillo A; Eickbush TH
J Biol Chem; 2002 Sep; 277(38):34836-45. PubMed ID: 12101182
[TBL] [Abstract][Full Text] [Related]
37. Effects of organic solvents on the reverse transcription reaction catalyzed by reverse transcriptases from avian myeloblastosis virus and Moloney murine leukemia virus.
Yasukawa K; Konishi A; Inouye K
Biosci Biotechnol Biochem; 2010; 74(9):1925-30. PubMed ID: 20834159
[TBL] [Abstract][Full Text] [Related]
38. The sequence features important for plus strand priming by human immunodeficiency virus type 1 reverse transcriptase.
Pullen KA; Rattray AJ; Champoux JJ
J Biol Chem; 1993 Mar; 268(9):6221-7. PubMed ID: 7681062
[TBL] [Abstract][Full Text] [Related]
39. Physiological magnesium concentrations increase fidelity of diverse reverse transcriptases from HIV-1, HIV-2, and foamy virus, but not MuLV or AMV.
Wang R; Belew AT; Achuthan V; El Sayed N; DeStefano JJ
J Gen Virol; 2021 Dec; 102(12):. PubMed ID: 34904939
[TBL] [Abstract][Full Text] [Related]
40. RNase H cleavage of tRNAPro mediated by M-MuLV and HIV-1 reverse transcriptases.
Smith CM; Potts WB; Smith JS; Roth MJ
Virology; 1997 Mar; 229(2):437-46. PubMed ID: 9126256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
